Loading drug information...
Failed to Load Drug Information
Please check your internet connection and try again.
# Phenaramine
## Overview
- **Classification**: First-generation Antihistamine, H1 receptor antagonist
- **Mechanism**: Competitively blocks histamine H1 receptors, preventing histamine's effects. Possesses significant anticholinergic and sedative properties.
## Primary Indications
1. **Allergic Rhinitis**: Relief of sneezing, rhinorrhea, and itchy nose/throat.
2. **Urticaria**: Management of allergic skin reactions and pruritus.
3. **Common Cold Symptoms**: Temporary relief of runny nose and sneezing.
## Adult Dosing
### Standard Dosing
**Allergic Rhinitis/Urticaria/Cold Symptoms**
- **Dose**: **25 mg**
- **Frequency**: Every **4-6 hours** as needed
- **Route**: Oral
- **Maximum Dose**: **150 mg/day** (in divided doses)
**Adjunctive Insomnia (Short-term)**
- **Dose**: **25-50 mg**
- **Frequency**: Once daily at bedtime
- **Route**: Oral
- **Maximum Dose**: **50 mg/day** for this indication
### Dose Adjustments
- **Renal Impairment**: CrCl <30 mL/min: Consider **dose reduction** or **extended interval** (e.g., Q8-12h).
- **Hepatic Impairment**: Use with caution; monitor for increased sedation. May require **dose reduction**.
- **Elderly Patients**: Start with **lower dose** (**12.5 mg**) due to increased sensitivity to anticholinergic effects and sedation. Avoid if possible.
## Pediatric Dosing
### Neonates (0-28 days)
- **Dose**: **Contraindicated**.
- **Special Notes**: High risk of respiratory depression and severe CNS effects. Avoid use.
### Infants (1-12 months)
- **Dose**: Generally **not recommended**.
- **Frequency**: N/A
- **Maximum**: N/A
- **Special Notes**: High risk of serious adverse effects. Use only if benefits clearly outweigh risks, with strict medical supervision and lowest possible dose (e.g., **1 mg/kg/day** divided, not exceeding **6.25 mg/dose**).
### Children (1-12 years)
- **Allergic Symptoms/Cold**: **1 mg/kg/day** divided into **4-6 doses**.
- **Dose (Age-based)**:
* **2-5 years**: **6.25 mg** every **4-6 hours**.
* **6-12 years**: **12.5-25 mg** every **4-6 hours**.
- **Frequency**: Every **4-6 hours** as needed
- **Route**: Oral
- **Maximum**: **75 mg/day** (2-5 years); **150 mg/day** (6-12 years).
- **Special Notes**: Monitor for paradoxical excitation. Liquid formulations are available.
### Adolescents (13-18 years)
- **Dose**: Use **adult dosing** of **25 mg**.
- **Frequency**: Every **4-6 hours** as needed
- **Route**: Oral
- **Maximum**: **150 mg/day** (in divided doses).
## Safety Information
### Contraindications
- **Absolute**: Narrow-angle glaucoma, prostatic hypertrophy with urinary retention.
- **Absolute**: Acute asthma attack, severe lower respiratory tract disease (e.g., COPD).
- **Absolute**: Concurrent use with MAOIs or within 14 days of stopping MAOI.
- **Absolute**: Neonates and premature infants.
- **Relative**: Breastfeeding (may cause sedation in infant).
### Common Adverse Effects
- **Very Common (>10%)**: Sedation, drowsiness, dizziness, impaired coordination.
- **Common (1-10%)**: Dry mouth, blurred vision, urinary retention, constipation, thickened bronchial secretions.
- **Serious but Rare**: Paradoxical excitation (especially in children), seizures (overdose), severe allergic reactions.
### Key Drug Interactions
- **CNS Depressants (Alcohol, Opioids, Benzodiazepines)**: Enhanced sedation and respiratory depression. Avoid concurrent use.
- **Anticholinergics (TCAs, Atropine, some antipsychotics)**: Increased anticholinergic effects. Monitor closely.
- **MAOIs (Isocarboxazid, Phenelzine)**: Intensified anticholinergic effects and CNS depression. **Contraindicated**.
## Monitoring & Follow-up
- **Before Treatment**: Assess for contraindications (e.g., glaucoma, prostate issues).
- **During Treatment**: Monitor for efficacy (symptom relief) and adverse effects (sedation, anticholinergic symptoms).
- **Clinical Signs**: Watch for excessive drowsiness, confusion, urinary difficulty, or unusual excitement.
## Clinical Pearls
- 💡 **Tip 1**: Significant sedation is common; advise patients to avoid driving or operating machinery.
- 💡 **Tip 2**: Best taken at night if used for daytime symptoms to minimize daytime drowsiness.
- 💡 **Tip 3**: May cause paradoxical excitation (restlessness/agitation) in young children.
- 💡 **Tip 4**: Advise patients to avoid alcohol and other CNS depressants due to additive effects.
- 💡 **Tip 5**: Not recommended for cold symptoms in children <2 years due to lack of efficacy and safety concerns.
> **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.